News

Tonix Pharmaceuticals (TNXP) Stock Surges Following Insider Buying And Q1 Results
Tonix stock surged over 33% this week fueled by insider buying and strong Q1 results. The company's Q1 loss beat estimates.
Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations
Mr. Hand brings more than 20 years of strategic legal and business leadership experience across multiple functions in the ...
Stocktwits on MSN4d
Tonix Pharma Stock Soars After Roping In Former Celgene Corp Executive Joseph Hand: Retail Gets More Positive
Shares of Tonix Pharmaceuticals Holding Corp. (TNXP) traded 12% higher on Wednesday noon after the company appointed Joseph ...
TipRanks on MSN1d
Tonix, Illumina, HP, Schwab & Carvana: Insider Moves!
Insiders have been trading these 5 stocks: (($TNXP)), (($ILMN)), (($HPE)), (($SCHW)) and (($CVNA)). Here is a breakdown of ...
Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would ...
American Association of Individual Investors3d
Why Tonix Pharmaceuticals Holding Corp.’s (TNXP) Stock Is Up 5.05%
Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 5.05%, which has investors questioning if this is right time to sell.
Seeking Alpha3d
Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations
As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. Tonix does not undertake an obligation to ...
Morningstar6d
Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
About Tonix Pharmaceuticals Holding Corp.* Tonix is a fully integrated biopharmaceutical company focused on transforming therapies for pain management and vaccines for public health challenges.